Benefits of bifidobacterium breve M-16V Supplementation in preterm neonates -A retrospective cohort study

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Patole, Sanjay K ^a,e   Rao, Shripada C ^b,e   Keil, Anthony D ^c   Nathan, Elizabeth A ^a,d   Doherty, Dorota A ^a,d   Simmer, Karen N ^a,e  

^a KING EDWARD MEMORIAL HOSPITAL   (Australia)

^b PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^c PATHWEST LABORATORY MEDICINE   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ARTICLE; BIFIDOBACTERIUM BREVE; BIRTH WEIGHT; CHILD SAFETY; COHORT ANALYSIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN MORTALITY; OUTCOME ASSESSMENT; PREMATURITY; RETROSPECTIVE STUDY; THERAPY EFFECT; ADVERSE EFFECTS; BIFIDOBACTERIUM; DIETARY SUPPLEMENT; ENTEROCOLITIS, NECROTIZING; INCIDENCE;

BIFIDOBACTERIUM; COHORT STUDIES; DIETARY SUPPLEMENTS; ENTEROCOLITIS, NECROTIZING; FEMALE; GESTATIONAL AGE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, PREMATURE; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PROBIOTICS; RETROSPECTIVE STUDIES;

EID: 84961181549     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0150775     Document Type: Article

References (50)

1. Neu J. Necrotizing enterocolitis. World Rev Nutr Diet 2014; 110:253-263. doi: 10.1159/000358474 PMID: 24751635
2. Neu J. Probiotics and necrotizing enterocolitis. Clin Perinatol 2014; 41:967-978. doi: 10.1016/j.clp. 2014.08.014 PMID: 25459784
3. Schulzke SM, Deshpande GC, Patole SK. Neurodevelopmental outcomes of very low-birth-weight infants with necrotizing enterocolitis: a systematic review of observational studies. Arch Pediatr Adolesc Med 2007; 161:583-590. PMID: 17548764
4. Choi YY. Necrotizing enterocolitis in newborns: update in pathophysiology and newly emerging therapeutic strategies. Korean J Pediatr 2014; 57: 505-13. doi: 10.3345/kjp.2014.57.12.505 PMID: 25653683
5. Tanner SM, Berryhill TF, Ellenburg JL, Jilling T, Cleveland DS, Lorenz RG, et al. Pathogenesis of necrotizing enterocolitis: modelling the innate immune response. Am J Pathol 2015; 185: 4-16. doi: 10. 1016/j.ajpath.2014.08.028 PMID: 25447054
6. Terrin G, Scipione A, De Curtis M. Update in pathogenesis and prospective in treatment of necrotizing enterocolitis. Biomed Res Int 2014; 2014:543765 doi: 10.1155/2014/543765 PMID: 25147804
7. Nanthakumar N, Meng D, Goldstein AM, Zhu W, Lu L, Uauy R, et al. The mechanism of excessive intestinal inflammation in necrotizing enterocolitis: an immature innate immune response. PLoS One 2011 Mar 21; 6:e17776. doi: 10.1371/journal.pone.0017776 PMID: 21445298
8. Meng D, Zhu W, Shi HN, Lu L, Wijendran V, Xu W, et al. Toll-like receptor-4 in human and mouse colonic epithelium is developmentally regulated: a possible role in necrotizing enterocolitis. Pediatr Res 2015; 77:416-424. doi: 10.1038/pr.2014.207 PMID: 25521917
9. Afrazi A, Branca MF, Sodhi CP, Good M, Yamaguchi Y, Egan CE, et al. Toll-like receptor 4-mediated endoplasmic reticulum stress in intestinal crypts induces necrotizing enterocolitis. J Biol Chem 2014; 289:9584-9599. doi: 10.1074/jbc.M113.526517 PMID: 24519940
10. Zhou W, Li W, Zheng XH, Rong X, Huang LG. Glutamine downregulates TLR-2 and TLR-4 expression and protects intestinal tract in preterm neonatal rats with necrotizing enterocolitis. J Pediatr Surg 2014; 49:1057-1063. doi: 10.1016/j.jpedsurg.2014.02.078 PMID: 24952788
11. Ofek Shlomai N, Deshpande G, Rao S, Patole S. Probiotics for preterm neonates: what will it take to change clinical practice? Neonatology 2014; 105:64-70. doi: 10.1159/000354891 PMID: 24281648
12. Patole SK, de Klerk N. Impact of standardised feeding regimens on incidence of neonatal necrotising enterocolitis: a systematic review and meta-analysis of observational studies. Arch Dis Child Fetal Neonatal Ed 2005; 90:F147-151. PMID: 15724039
13. Uauy RD, Fanaroff AA, Korones SB, Phillips EA, Phillips JB, Wright LL. Necrotizing enterocolitis in very low birth weight infants: biodemographic and clinical correlates. National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1991; 119:630-638. PMID: 1919897
14. Flidel-Rimon O, Branski D, Shinwell ES. The fear of necrotizing enterocolitis versus achieving optimal growth in preterm infants-an opinion. Acta Paediatr 2006; 95:1341-1344. PMID: 17062457
15. Food and Agriculture Organization of the United Nations, and World Health Organization. Report of a Joint FAO/WHO Expert Consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Cordoba, Argentina: FAO/WHO, 2001.
16. AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2014 Apr 10; 4:CD005496. doi: 10.1002/14651858.CD005496.pub4 PMID: 24723255
17. Yang Y, Guo Y, Kan Q, Zhou XG, Zhou XY, Li Y. A meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Braz J Med Biol Res 2014; 47:804-810. PMID: 25098619
18. Bernardo WM, Aires FT, Carneiro RM, Sá FP, Rullo VE, Burns DA. Effectiveness of probiotics in the prophylaxis of necrotizing enterocolitis in preterm neonates: a systematic review and meta-analysis. J Pediatr (Rio J) 2013; 89:18-24.
19. Wang Q, Dong J, Zhu Y. Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials. J Pediatr Surg 2012; 47:241-248. doi: 10.1016/j.jpedsurg.2011.09.064 PMID: 22244424
20. Guthmann F, Kluthe C, Bührer C. Probiotics for prevention of necrotising enterocolitis: an updated meta-analysis. Klin Padiatr 2010; 222:284-290. doi: 10.1055/s-0030-1254113 PMID: 20645240
21. Deshpande G, Rao S, Patole S, Bulsara M. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010; 125:921-930. doi: 10.1542/peds.2009-1301 PMID: 20403939
22. Rowland I, Capurso L, Collins K, Cummings J, Delzenne N, Goulet O, et al. Current level of consensus on probiotic science-report of an expert meeting-London, 23 November 2009. Gut Microbes 2010; 1:436-439. doi: 10.4161/gmic.1.6.13610 PMID: 21637035
23. Kekkonen RA. Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults. World J Gastroenterol 2008; 14:2029-2036. PMID: 18395902
24. Salminen S. Human studies on probiotics: Aspects of scientific documentation. Scandinavian Journal of Nutrition 2001; 45:8-12.
25. Barclay AR, Stenson B, Simpson JH, Weaver LT, Wilson DC. Probiotics for necrotizing enterocolitis: a systematic review. J Pediatr Gastroenterol Nutr 2007; 45:569-576. PMID: 18030235
26. Mihatsch WA, Braegger CP, Decsi T, Kolacek S, Lanzinger H, Mayer B, et al. Critical systematic review of the level of evidence for routine use of probiotics for reduction of mortality and prevention of necrotizing enterocolitis and sepsis in preterm infants. Clin Nutr 2012; 31:6-15. doi: 10.1016/j.clnu.2011.09. 004 PMID: 21996513
27. Soll RF. Probiotics: are we ready for routine use? Pediatrics 2010; 125:1071-1072. doi: 10.1542/peds. 2010-0643 PMID: 20421256
28. Garland SM, Jacobs SE, Tobin JM, Opie GF, Donath S, ProPrems study group. A cautionary note on instituting probiotics into routine clinical care for premature infants. Pediatrics 2010; 126:e741-2. doi: 10.1542/peds.2010-1949B PMID: 20810714
29. Beattie LM, Hansen R, Barclay AR. Probiotics for preterm infants: confounding features warrant caution. Pediatrics 2010; 126:e742-743. doi: 10.1542/peds.2010-1949C PMID: 20810715
30. Modi N. Probiotics and necrotising enterocolitis: the devil (as always) is in the detail. Neonatology 2014; 105:71-73. doi: 10.1159/000354909 PMID: 24296920
31. Vandenplas Y, Veereman-Wauters G. Probiotics: fishing in the ocean. J Pediatr Gastroenterol Nutr 2012; 54:4-5. doi: 10.1097/MPG.0b013e3182333de3 PMID: 21873896
32. Ganguli K, Walker AW. Probiotics in the prevention of necrotizing enterocolitis. J Clin Gastroenterol. 2011; 45:S133-138. doi: 10.1097/MCG.0b013e318228b799 PMID: 21992952
33. Saunders ME. Is it time to consider generic probiotic effects? California Dairy Research Foundation. 1st March/2013. Available:http://cdrf.org/2013/03/01/is-it-time-to-consider-generic-probiotic-effects/. Accessed: 10 April 2015
34. Olsen R, Greisen G, Schrøder M, Brok J. Prophylactic probiotics for preterm infants: a systematic review and meta-Analysis of observational studies. Neonatology 2015; 109:105-112. doi: 10.1159/ 000441274 PMID: 26624488
35. Patole S, Keil AD, Chang A, Nathan E, Doherty D, Simmer K, et al. Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates-a randomised double blind placebo controlled trial. PLoS One 2014 Mar 3; 9:e89511. doi: 10.1371/journal.pone.0089511 PMID: 24594833
36. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Ann Surg 1978; 187:1-7. PMID: 413500
37. Therapeutic Goods Administration (TGA, Canberra), The Authorised prescriber Pathway. Available: https://www.tga.gov.au/form/authorised-prescribers. Accessed: 15 April 2015 http://www.bd.com/ds/ productCenter/442194.asp
38. The Australia New Zealand neonatal network (ANZNN): Available: https://npesu.unsw.edu.au/datacollection/australian-new-zealand-neonatal-network-anznn.
39. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ. 2007; 85:867-872. PMID: 18038077
40. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978; 92:529-534. PMID: 305471
41. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 2005; 123:991-999. PMID: 16009843
42. Satoh Y, Shinohara K, Umezaki H, Shoji H, Satoh H, Ohtsuka H, et al. Bifidobacteria prevents necrotising enterocolitis and infection in preterm infants. International Journal of Probiotics and Prebiotics 2007; 2:149-154.
43. Hickey L, Garland SM, Jacobs SE, O'Donnell CP, Tabrizi SN, ProPrems Study Group. Cross-colonization of infants with probiotic organisms in a neonatal unit. J Hosp Infect 2014; 88:226-229. doi: 10. 1016/j.jhin.2014.09.006 PMID: 25447201
44. Kitajima H, Sumida Y, Tanaka R, Yuki N, Takayama H, Fujimura M. Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 1997; 76: F101-107. PMID: 9135288
45. Costeloe KL, Jesudass R, Al Nakib L, Whiley A, Wilks M, Millar MR. The early administration of Bifidobacterium breve strain BBG to very low birthweight infants: a pilot study. Pediatric Academic Societies Meeting, San Francisco, May 2004 Pediatr Res 2004; 55:2802 (Pt 2802 Supp S).
46. Costeloe K, Hardy P, Juszczak E, Wilks M, Millar MR, Probiotics in Preterm Infants Study Collaborative Group. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet. 2015 Nov 25. pii:S0140-6736(15)01027-2.
47. Janvier A, Malo J, Barrington KJ. Cohort study of probiotics in a North American neonatal intensive care unit. J Pediatr 2014; 164:980-985. doi: 10.1016/j.jpeds.2013.11.025 PMID: 24411521
48. Repa A, Thanhaeuser M, Endress D, Weber M, Kreissl A, Binder C, et al. Probiotics (Lactobacillus acidophilus and Bifidobacterium bifidum) prevent NEC in VLBW infants fed breast milk but not formula. Pediatr Res 2015; 77:381-388. doi: 10.1038/pr.2014.192 PMID: 25423074
49. Härtel C, Pagel J, Rupp J, Bendiks M, Guthmann F, Rieger-Fackeldey E, et al. German Neonatal Network. Prophylactic use of Lactobacillus acidophilus/Bifidobacterium infantis probiotics and outcome in very low birth weight infants. J Pediatr 2014; 165:285-289.
50. Fatal Gastrointestinal Mucormycosis in an infant following use of contaminated ABC Dophilus powder from Solgar Inc. Available: http://www.cdc.gov/fungal/outbreaks/rhizopus-investigation.html. Accessed: 6 April 2015.